Overview

Update
Status
Acquired by on March 30, 2015
IPO / Stock
Went Public on Jul 26, 2012 / NASDAQ:HPTX
Headquarters:
South San Francisco, CA
Description:
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.
Founders:
Categories:
Biopharma, Therapeutics, Health Care, Biotechnology
Website:
http://www.hyperiontx.com
Social:

Funding Rounds (7) - $165.96M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2011$7.5M / Debt Financing0
Apr, 2011$17.47M / Venture0
Jun, 2009$60M / Series C5
May, 2009$13M / Debt Financing0
May, 2009$12.99M / Debt Financing0
Oct, 2007$15M / Debt Financing2
Sep, 2007$40M / Series B4

Acquisitions (1)

Update

Current Team (7)

Update

Offices/Locations (1)

Update
  • Corporate Headquarters

    601 Gateway Blvd.

    Suite 200

    South San Francisco, CA 94080

    USA

Past Team (2)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos